Medication Assisted Treatment (MAT)
What is MAT?
Medication Assisted Treatment (MAT) is an evidence-based treatment approach wherein a client receives counseling services in conjunction with medications designed to manage craving and withdrawal symptoms from opioid/alcohol use.
How do i receive mat services?
Patients who are interested in Medication Assisted Treatment (MAT) will attend an initial assessment with one of our psychiatric providers to create an individualized treatment plan based on their needs.
At that assessment, these different formulations of buprenorphine:
buprenorphine films
oral pills
subcutaneous injection
OR naltrexone
will be discussed and a personalized recommendation for treatment will be provided.
What makes quest’s mat approach different?
At Quest, we offer various formulations of buprenorphine to help manage opioid dependency by reducing withdrawal symptoms and cravings. This regulated treatment supports safer substance use reduction. As a partial opioid agonist, buprenorphine has a lower risk of respiratory depression, overdose, and dependency compared to methadone, making it easier for patients to taper off when ready.
Who Qualifies for mat?
Anyone ages 17 and older with a history of opioid/alcohol use or misuse who would benefit from MAT services.
Expanding Access to Medication-Assisted Treatment
Quest is committed to reducing barriers to care and expanding access to Medication-Assisted Treatment (MAT) for Native American and Alaska Native individuals affected by opioid use disorder.
Through funding from the Indian Health Service’s Community Opioid Intervention Prevention Program (COIPP), awarded to Nevada Urban Indians, Inc., this program provides culturally responsive, evidence-based care designed to support each person’s unique recovery journey.
How We Can Help
MAT, counseling, and individualized support tailored to your needs and recovery goals.
Connections to community resources and coordinated care to support your overall well-being.
Support may be available to help reduce transportation barriers and make it easier to attend appointments.
Eligible participants may receive incentives to encourage continued engagement in treatment.
This program is supported by the Indian Health Service through a pass-through award from Nevada Urban Indians, Inc., under the Community Opioid Intervention Prevention Program (COIPP). The total project cost is $111,675.00, of which 100% is financed with Federal funds.
We look forward to supporting you on your sobriety journey and welcome any questions about this program. Please contact us at (775) 786-6880 for more information on these medications or to schedule an appointment.